Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Unleashing Creativity in Virtual Pharma Engagements

June 20, 2024 | DOL engagement, KOL Engagement, Pharma engagement, Pharma meeting, Pharma trends, Virtual Meeting, Virtual Pharma, insight gathering 

Think outside the box with virtual engagements! Discover how creative asynchronous touchpoints can revolutionize your interactions. Explore everything from OLAs to treatment pathway profiling via a pharma-compliant virtual platform.

Explore the boundless potential of asynchronous touchpoints with our final tip in the series. Learn how creativity can redefine the scope and impact of your virtual interactions on the Impetus InSite Platform®.

10. Be Creative
Step beyond traditional advisory boards and team meetings. The Impetus InSite Platform® offers a versatile canvas for engaging participants in innovative ways. Whether it’s through Online Learning Activities (OLAs), journal clubs, case study discussions, post-(virtual) conference debriefs, patient journey mapping, or treatment pathway profiling, there’s a multitude of creative possibilities to explore. Embrace the flexibility of asynchronous touchpoints to craft unique and compelling engagement experiences that captivate and educate your participants.

This tip encourages you to think outside the box and discover new ways to leverage virtual tools for enhanced communication and deeper insight gathering.

For more creative strategies and insights into maximizing your virtual engagements, check out our blog: https://www.impetusdigital.com/2020/05/12/top-10-tips-for-optimizing-asynchronous-virtual-meetings/

Elevate your virtual engagements with Impetus Digital:

Stay connected for more creative ideas and updates:

This content was provided by Impetus Digital

Company Details

- PMLiVE

Impetus Digital

Email
Website

 Latest Content from  Impetus Digital 

Beat inflation with virtual meetings and programs

At the time of writing, the average inflation rate worldwide sits at 7.4%, the highest it’s been for decades. Here in Canada, the inflation rate is not forecasted to come back down...

Engaging KOLs & Gaining Insights in Pharma’s New Normal

Kaitlin Anstett, Senior Medical Advisor at Theratechnologies, shares her unique insights into the way Medical Affairs teams are changing the way they are engaging and interacting with their most important...

Learning Program Webinar Series & Community Board

A Customer Story

There’s No Going Back: How COVID-19 will Change Pharma Forever

Munther Baara, VP Product Strategy and Innovation at EDETEK, discusses all things clinical trials. Especially, we discuss the current gaps and the impact of COVID-19 on the way Pharma approaches...

Powering Rapid Cognitive Analysis with AI

Dr. Tom Sawyer, CFO at Cognetivity Neurosciences, discusses the benefits of AI-driven dementia detection technology for patients, health care providers, and clinical research.

KOL Ambassador Program & Podcast Creation: A Customer Story

Leveraging Impetus Digital’s best-in-class synchronous (real-time) and asynchronous (over-time, anytime) tools, our client facilitated a virtual ambassador program with three oncologist key opinion leaders (KOLs) from South Korea.The client’s main objectives...

Importance of Emotional Intelligence in Pharma and Medical Affairs

Emma Lynch, Founder of EQ Vibration & Quadrant 2 Medical, explores a number of interesting topics related to Medical Affairs. Among many other things, she discusses the importance of emotional...

Virtual product launch planning: the ultimate playbook

We walk you through, step-by-step, how cross-functional teams can seamlessly work together and overcome the many obstacles associated with traditional product launches.

Artificial Intelligence for Identifying and Monitoring Cognitive Decline

Liam Kaufman, CEO & Co-founder of Winterlight Labs, explores a range of topics related to AI, machine learning, natural language processing, digital biomarkers, and human-computer interactions in healthcare.

Trust and transparency in Pharma & healthcare: impact of the COVID-19 pandemic

While it is obvious that trust in life science and healthcare companies is suboptimal, exactly how to improve the public’s trust is unclear...